Von Willebrand disease , vWD (Abkürzung)

This medication should not be used to treat von Willebrand disease.

Human antihemophilic factor is not for use in people with von Willebrand disease.

This phenomenon is characterised by a form of von Willebrand disease (type 2a).

The oldest two sons had inherited their mother's bleeding disorder, von Willebrand disease.

Human antihemophilic factor will not treat von Willebrand disease.

New research is concluding that the von Willebrand disease is much more common in adolescence.

If you have Von Willebrand disease, medication is available, but you'll likely want to see a hematologist for treatment.

Von Willebrand disease is an inherited bleeding disorder.

Von Willebrand disease is inherited as an autosomal dominant or recessive trait.

Haemophilia A can be mimicked by von Willebrand disease.

The tests normally performed for Von Willebrand disease are not necessarily positive, as the abnormality is subtle.

Various types of Hemophilia and von Willebrand disease are the major genetic disorders associated with coagulopathy.

The team also investigated Von Willebrand disease, and studied the effects of snake venom on blood clotting.

This bleeding disorder is called "Von Willebrand Disease".

Diseases that affect the blood, such as anemia, hemochromatosis, hemophilia, thalassemia, and von Willebrand disease.

In individuals with von Willebrand disease, platelets do not stick to holes in blood vessels and bleeding is prolonged.

For example, in von Willebrand Disease, the platelets cannot stick together or cannot attach to blood vessel walls.

Mutations within vWF are the usual cause of the most common inherited bleeding disorder, von Willebrand disease.

Patients with von Willebrand disease will typically display a normal prothrombin time and a variable prolongation of partial thromboplastin time.

A rarer culprit for heavy periods may be a bleeding disorder like Von Willebrand disease, which makes it hard for your blood to clot.

Infusion of platelet concentrates is recommended for correction of hemorrhage associated with platelet-type von Willebrand disease.

Desmopressin used in the treatment of type 1 von Willebrand disease is, in general, given every 12-24 hours in limited numbers due to its tachyphylactic properties.

It is due to the induction of von Willebrand disease type IIA by the valvular stenosis.

Von Willebrand was the first to describe the blood coagulation disorder later named for him, von Willebrand disease.

Wear a medical alert tag or carry an ID card stating that you have hemophilia or von Willebrand disease in case of emergency.